Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

Carlsmed (Nasdaq: CARL) will report fourth quarter and full year 2025 financial results after market close on Wednesday, February 25, 2026.

Rhea-AI Summary

Carlsmed (Nasdaq: CARL) will report fourth quarter and full year 2025 financial results after market close on Wednesday, February 25, 2026. Management will host a conference call and concurrent webcast at 1:30 PM Pacific Time, with a replay archived on the company's website.

Argus Feb 12 session

-5.78% close to close Open Argus

Details

News Market Reaction – CARL

On Feb 12, the first trading day after this news, CARL closed 5.78% below the previous close.

Data tracked by StockTitan Argus for the Feb 12 session.

Market Context

On Feb 12, the first trading day after this news, the stock closed 5.8% below the previous close. A ...

Analysis

On Feb 12, the first trading day after this news, the stock closed 5.8% below the previous close. A negative reaction despite this being mainly an earnings-timing announcement would fit occasional divergence seen around operational updates, such as the flat move after the first bilateral lumbar procedure despite its positive tone. Prior filings highlight expanding credit facilities and ongoing losses alongside strong revenue growth, which may have heightened sensitivity to future guidance or margin commentary that the scheduled earnings call could reveal.

Key Figures

Earnings release date: February 25, 2026 Conference call time: 1:30 PM Pacific Time

Earnings release date

February 25, 2026

Scheduled Q4 and full year 2025 results release

Conference call time

1:30 PM Pacific Time

Start time for earnings call and webcast

Historical Context

5 past events · Latest: Feb 10

5 events

1. Feb 10

   Product usage milestone

   24h Move

   -0.1%

   First aprevo lumbar bi-lateral posterior fusion procedure at Colorado hospital.

2. Jan 12

   Preliminary revenue update

   24h Move

   +13.8%

   Preliminary Q4 and 2025 revenue with strong year-over-year growth and user gains.

3. Jan 06

   Clinical data publication

   24h Move

   +2.9%

   Two-year lumbar data showing lower revision rates versus conventional implants.

4. Dec 16

   Conference participation

   24h Move

   +0.0%

   Planned presentation and investor meetings at J.P. Morgan 2026 Healthcare Conference.

5. Dec 03

   Product launch

   24h Move

   +12.4%

   U.S. launch of aprevo cervical platform with early clinical experience data.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CARLSBAD, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its fourth quarter and full year 2025 financial results after market close on Wednesday, February 25, 2026. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time.

Conference Call Information

To participate in this event, dial in approximately 5 to 10 minutes before the start of the conference call.

Event Date: Wednesday, February 25, 2026
Time: 1:30 PM Pacific Time

Participant Registration: https://register-conf.media-server.com/register/BIb4506be22c484ba7a7767032cba20986

A replay of the webcast will be available shortly after the conclusion of the call and will be archived on the company's website here.

About Carlsmed

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

Investor Relations
IR@Carlsmed.com

Media

LeAnn Burton
Senior Director Brand Marketing
LBurton@Carlsmed.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Carlsmed (CARL) release its Q4 and full year 2025 results?

Carlsmed will release Q4 and full year 2025 results after market close on February 25, 2026. According to the company, management will follow the release with a conference call and webcast at 1:30 PM Pacific Time to discuss the results and answer questions.

What time is the Carlsmed (CARL) earnings conference call on February 25, 2026?

The Carlsmed conference call is scheduled for 1:30 PM Pacific Time on February 25, 2026. According to the company, a concurrent webcast will be available and a replay will be archived on the company's website shortly after the call concludes.

How can investors join the Carlsmed (CARL) Feb 25, 2026 earnings webcast?

Investors can join the Carlsmed webcast via the provided registration link before the event. According to the company, participants should dial in 5 to 10 minutes early and the webcast replay will be posted on the company's website after the call.

Will Carlsmed (CARL) provide a replay of the February 25, 2026 earnings call?

Yes, a replay of the Carlsmed earnings webcast will be available shortly after the call and archived on the company's website. According to the company, the archived replay will remain accessible for investors who cannot attend the live event.

What topics will Carlsmed (CARL) management likely cover in the February 25, 2026 call?

Management will discuss fourth quarter and full year 2025 financial results and answer analyst questions on performance. According to the company, the call and webcast are intended to provide an overview of results and management's perspective on recent developments.

Is prior registration required to attend Carlsmed's (CARL) Feb 25, 2026 earnings call?

Registration is provided and recommended via the company's conference registration link ahead of the event. According to the company, participants should register and dial in 5 to 10 minutes before the 1:30 PM Pacific Time start.